CN116251231A - 一种注射用美容填充材料及其制备方法 - Google Patents
一种注射用美容填充材料及其制备方法 Download PDFInfo
- Publication number
- CN116251231A CN116251231A CN202210700156.5A CN202210700156A CN116251231A CN 116251231 A CN116251231 A CN 116251231A CN 202210700156 A CN202210700156 A CN 202210700156A CN 116251231 A CN116251231 A CN 116251231A
- Authority
- CN
- China
- Prior art keywords
- chitosan
- hyaluronic acid
- solution
- gel
- mass concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011049 filling Methods 0.000 title claims abstract description 56
- 238000002347 injection Methods 0.000 title claims abstract description 45
- 239000007924 injection Substances 0.000 title claims abstract description 45
- 239000000463 material Substances 0.000 title claims abstract description 44
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000004005 microsphere Substances 0.000 claims abstract description 145
- 229920001661 Chitosan Polymers 0.000 claims description 121
- 239000000243 solution Substances 0.000 claims description 117
- 229920002674 hyaluronan Polymers 0.000 claims description 104
- 229960003160 hyaluronic acid Drugs 0.000 claims description 104
- 238000003756 stirring Methods 0.000 claims description 74
- 239000002131 composite material Substances 0.000 claims description 69
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 67
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 60
- -1 hydroxybutyl Chemical group 0.000 claims description 54
- 238000002156 mixing Methods 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 47
- 229960002989 glutamic acid Drugs 0.000 claims description 44
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 43
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 40
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000004220 glutamic acid Substances 0.000 claims description 35
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 31
- 108010039918 Polylysine Proteins 0.000 claims description 29
- 239000007864 aqueous solution Substances 0.000 claims description 29
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- 239000007908 nanoemulsion Substances 0.000 claims description 26
- 239000000839 emulsion Substances 0.000 claims description 24
- 238000001035 drying Methods 0.000 claims description 22
- 238000005406 washing Methods 0.000 claims description 22
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 21
- 239000004626 polylactic acid Substances 0.000 claims description 21
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 16
- 229940057995 liquid paraffin Drugs 0.000 claims description 16
- 239000002244 precipitate Substances 0.000 claims description 14
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 13
- 235000013922 glutamic acid Nutrition 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 11
- 238000004108 freeze drying Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 230000009969 flowable effect Effects 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 8
- 229920000053 polysorbate 80 Polymers 0.000 claims description 8
- 229940024606 amino acid Drugs 0.000 claims description 7
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 26
- 230000015556 catabolic process Effects 0.000 abstract description 19
- 238000006731 degradation reaction Methods 0.000 abstract description 19
- 102000008186 Collagen Human genes 0.000 abstract description 13
- 108010035532 Collagen Proteins 0.000 abstract description 13
- 229920001436 collagen Polymers 0.000 abstract description 13
- 238000007493 shaping process Methods 0.000 abstract description 13
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 3
- 210000004207 dermis Anatomy 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 206010057249 Phagocytosis Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 230000001815 facial effect Effects 0.000 abstract description 2
- 230000008782 phagocytosis Effects 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 106
- 230000000052 comparative effect Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 238000004132 cross linking Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 4
- 230000008093 supporting effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 241000531116 Blitum bonus-henricus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000008645 Chenopodium bonus henricus Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 230000004537 potential cytotoxicity Effects 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
- Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
注射10天后背部变化 | 注射40天后背部变化 | 注射100天后背部变化 | |
实施例1 | 光滑、平整、透亮 | 光滑、平整、透亮 | 光滑、不平整、透亮 |
实施例2 | 光滑、平整、透亮 | 光滑、平整、透亮 | 光滑、不平整、透亮 |
实施例3 | 光滑、平整、透亮 | 光滑、平整、透亮 | 光滑、平整、透亮 |
实施例4 | 光滑、平整、透亮 | 光滑、平整、透亮 | 光滑、平整、透亮 |
实施例5 | 光滑、平整、透亮 | 光滑、平整、透亮 | 光滑、平整、透亮 |
对比例1 | 光滑、不平整、透亮 | 光滑、不平整、暗淡 | 不光滑、不平整、暗淡 |
对比例2 | 光滑、不平整、透亮 | 光滑、不平整、暗淡 | 不光滑、不平整、暗淡 |
酶解率(%) | |
实施例1 | 50.21 |
实施例2 | 50.24 |
实施例3 | 43.14 |
实施例4 | 43.16 |
实施例5 | 43.11 |
对比例1 | 55.32 |
对比例2 | 60.24 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210700156.5A CN116251231B (zh) | 2022-06-20 | 2022-06-20 | 一种注射用美容填充材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210700156.5A CN116251231B (zh) | 2022-06-20 | 2022-06-20 | 一种注射用美容填充材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116251231A true CN116251231A (zh) | 2023-06-13 |
CN116251231B CN116251231B (zh) | 2024-03-29 |
Family
ID=86681401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210700156.5A Active CN116251231B (zh) | 2022-06-20 | 2022-06-20 | 一种注射用美容填充材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116251231B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002293747A (ja) * | 2001-03-29 | 2002-10-09 | Jinen:Kk | 皮膚外用剤 |
CN104147640A (zh) * | 2013-05-16 | 2014-11-19 | 吴学森 | 右旋聚乳酸微纳米颗粒用作美容整形填充物及其制备方法 |
BR102014031056A2 (pt) * | 2014-12-11 | 2016-07-12 | Univ Estadual Ponta Grossa | processo de preparação de nanopartículas de ácido hialurônico e polilisina, e de ácido hialurônico e lisina, por interação iônica, para preenchimento cutâneo |
CN108653818A (zh) * | 2018-05-24 | 2018-10-16 | 上海其胜生物制剂有限公司 | 一种可逆的胶原刺激填充剂及其制备方法 |
CN110038161A (zh) * | 2019-04-29 | 2019-07-23 | 上海交通大学 | 一种新型透明质酸流动凝胶及其制备方法和应用 |
CN111388755A (zh) * | 2020-03-20 | 2020-07-10 | 东华大学 | 一种可注射型透明质酸/壳聚糖水凝胶及其制备方法 |
CN113730652A (zh) * | 2021-09-01 | 2021-12-03 | 北京大清生物技术股份有限公司 | 一种注射用混合凝胶及其制备方法和应用 |
-
2022
- 2022-06-20 CN CN202210700156.5A patent/CN116251231B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002293747A (ja) * | 2001-03-29 | 2002-10-09 | Jinen:Kk | 皮膚外用剤 |
CN104147640A (zh) * | 2013-05-16 | 2014-11-19 | 吴学森 | 右旋聚乳酸微纳米颗粒用作美容整形填充物及其制备方法 |
BR102014031056A2 (pt) * | 2014-12-11 | 2016-07-12 | Univ Estadual Ponta Grossa | processo de preparação de nanopartículas de ácido hialurônico e polilisina, e de ácido hialurônico e lisina, por interação iônica, para preenchimento cutâneo |
CN108653818A (zh) * | 2018-05-24 | 2018-10-16 | 上海其胜生物制剂有限公司 | 一种可逆的胶原刺激填充剂及其制备方法 |
CN110038161A (zh) * | 2019-04-29 | 2019-07-23 | 上海交通大学 | 一种新型透明质酸流动凝胶及其制备方法和应用 |
CN111388755A (zh) * | 2020-03-20 | 2020-07-10 | 东华大学 | 一种可注射型透明质酸/壳聚糖水凝胶及其制备方法 |
CN113730652A (zh) * | 2021-09-01 | 2021-12-03 | 北京大清生物技术股份有限公司 | 一种注射用混合凝胶及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
张伟强: "《固态金属及合金中的相变》", vol. 1, 国防工业出版社, pages: 322 - 323 * |
Also Published As
Publication number | Publication date |
---|---|
CN116251231B (zh) | 2024-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106589424B (zh) | 一种注射用交联透明质酸凝胶及其制备方法 | |
US9782490B2 (en) | Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel | |
RU2692800C2 (ru) | Вязкоэластичные гели в качестве новых наполнителей | |
CN102229705B (zh) | 一种胶原蛋白温敏型水凝胶及其制备方法 | |
TWI430815B (zh) | 用於皮內注射之玻尿酸膠 | |
CN102836465A (zh) | 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用 | |
ES2883839T3 (es) | Hidrogeles de hialuronano coacervados para aplicaciones de relleno dérmico | |
CN104147640A (zh) | 右旋聚乳酸微纳米颗粒用作美容整形填充物及其制备方法 | |
US20210308332A1 (en) | Hydrogel compositions encapsulating solid particles | |
CN110964215A (zh) | 一种注射用左旋聚乳酸和交联透明质酸复合凝胶的制备方法及所得产品 | |
CN104774337A (zh) | 注射用含琼脂糖微球交联透明质酸钠凝胶及制备方法 | |
CN110812270B (zh) | 一种用于水光注射的透明质酸凝胶组合物及其制备方法 | |
CN114904049A (zh) | 含透明质酸和胶原蛋白的聚己内酯微球凝胶及其制备方法 | |
CN110327488A (zh) | 一种注射填充微球制剂及其制备方法 | |
CN102492032A (zh) | 类人胶原蛋白及注射型类人胶原蛋白软组织填充材料 | |
CN116251231B (zh) | 一种注射用美容填充材料及其制备方法 | |
CN116396498A (zh) | 一种交联聚谷氨酸凝胶及其制备方法和应用 | |
CN105903081A (zh) | 一种新型双层蛋白多糖基修复材料的制备方法 | |
CN113413330A (zh) | 一种胶原蛋白和左旋聚乳酸的复配方法及复配制剂 | |
EP3252081A1 (en) | Hydrolysis of ester bonds in amide crosslinked glycosaminoglycans | |
US20090023631A1 (en) | Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery | |
EP2178908A1 (en) | Peptides and pharmaceutical compositions for treating connective tissue | |
CN108578770A (zh) | 一种具有长效功能的注射医疗美容悬浮液及制备方法 | |
EP3252080A1 (en) | Method for preparing acylated crosslinked glycosaminoglycans | |
CN114404355B (zh) | 透明质酸钠凝胶及其制备方法、应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240306 Address after: 611130 Kangyi Road, Chengdu Cross Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City, Sichuan Province Applicant after: Chengdu Xihongyanmei Biotechnology Co.,Ltd. Country or region after: China Address before: 215600 building 16, 27 Jinxing Road, Jinfeng Town, Zhangjiagang City, Suzhou City, Jiangsu Province Applicant before: Jiangsu Dongfang Yanmei Biotechnology Development Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |